Healthcare -
Biotechnology - NASDAQ - US
$ 21.47
-2.36 %
$ 1.05 B
Market Cap
-11.36
P/E
ELVN - SHORT-TERM DEBT
Short-term Debt ELVN - Enliven Therapeutics, Inc.
335 K
LAST VALUE
45.15%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR